Evaluation of the Effectiveness of Montelukast in Children With Recurrent Obstructive Bronchitis

Effectiveness of Montelukast in Children With Recurrent Obstructive Bronchitis

The aim of the study was to evaluate the effectiveness of montelukast sodium in the treatment and prevention of recurrent obstructive bronchitis in children. The investigators examined 80 children aged 1 to 7 years with recurrent obstructive bronchitis, who were randomly divided into 2 groups.

The aim of the study was to evaluate the effectiveness of montelukast sodium in the treatment and prevention of recurrent obstructive bronchitis in children. The investigators examined 80 children aged 1 to 7 years with recurrent obstructive bronchitis, who were randomly divided into 2 groups. Group I (control) included 40 patients who received standard therapy and placebo. Group II (main) included 40 patients who received standart therapy and oral montelukast sodium.

Inclusion Criteria:

• RDA score=6 points
• E:I index score >1.40
• ineffective treatment at home for ≥48 hours
• adverse comorbidities

Exclusion Criteria:

• chronic or congenital diseases of the Central nervous, cardiovascular and bronchopulmonary systems